Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimicrobial chemotherapy.

I Chopra1

  • 1Antimicrobial Research Centre, University of Leeds, Leeds, LS2 9JT, UK. i.chopra@leeds.ac.uk

Idrugs : the Investigational Drugs Journal
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous thromboembolism in adult elective spinal surgery: a tertiary centre review of 2181 patients.

The bone & joint journal·2017
Same author

Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ).

The Journal of antimicrobial chemotherapy·2013
Same author

Pilocytic astrocytoma mimicking craniopharyngioma: a case series.

Annals of the Royal College of Surgeons of England·2012
Same author

Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.

Diabetologia·2011
Same author

Towards new business models for R&D for novel antibiotics.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2011
Same author

Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus.

Antimicrobial agents and chemotherapy·2010
Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010
Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010
Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010
Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010
Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010
Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010
See all related articles

Antimicrobial chemotherapy, including antiviral, antibacterial, and antifungal treatments, was discussed. The urgent issue of antibiotic resistance in bacteria was a key focus.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial chemotherapy encompasses antiviral, antibacterial, and antifungal strategies.
  • The emergence of antimicrobial resistance is a significant global health concern.

Purpose of the Study:

  • To review current advancements in antimicrobial chemotherapy.
  • To highlight the critical challenge of antibiotic resistance in bacterial pathogens.

Main Methods:

  • The content is based on discussions and presentations from the International Congress of Chemotherapy.
  • Focus on the emergence of antibiotic resistance in clinical bacterial isolates.

Main Results:

  • Key aspects of antiviral, antibacterial, and antifungal chemotherapy were covered.

Related Experiment Videos

  • A particular emphasis was placed on the increasing prevalence of antibiotic resistance.

    • Conclusions:

    • Continued research and vigilance are necessary to combat antimicrobial resistance.
    • Effective antimicrobial chemotherapy strategies remain crucial in clinical practice.